SCHEMBL571547

SCHEMBL571547

CCCCCCCCC=C[SiH](C)[O]

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 4/20 0.52
TRPV1 Q8NER1 1/20 0.52
TSHR P16473 1/20 0.46
TERT O14746 3/20 0.45
PTPN1 P18031 3/20 0.45
PPARG P37231 3/20 0.45
PPARD Q03181 3/20 0.45
PPARA Q07869 3/20 0.45
CYP1A2 P05177 2/20 0.45
MAPT P10636 2/20 0.45
CYP2C19 P33261 2/20 0.45
BLM P54132 2/20 0.45
HSD17B10 Q99714 2/20 0.45
FABP4 P15090 2/20 0.45
KMT2A Q03164 2/20 0.45
GMNN O75496 1/20 0.45
USP2 O75604 1/20 0.45
LMNA P02545 1/20 0.45
POLB P06746 1/20 0.45
CYP2C9 P11712 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL571546 1.00 FAAH (0.52) FAAHTRPV1TSHRTERTPTPN1
SCHEMBL571058 0.91
SCHEMBL571059 0.91
SCHEMBL571305 0.85 TSHR (0.53) FAAHTRPV1TSHR
SCHEMBL571304 0.85 TSHR (0.53) FAAHTRPV1TSHR
SCHEMBL16210018 0.81 FAAH (0.50) FAAHTRPV1TSHRTERTPTPN1
SCHEMBL16210017 0.81 FAAH (0.50) FAAHTRPV1TSHRTERTPTPN1
SCHEMBL16209865 0.81 FAAH (0.50) FAAHTRPV1TSHRTERTPTPN1
SCHEMBL16209690 0.81 FAAH (0.50) FAAHTRPV1TSHRTERTPTPN1
SCHEMBL16209691 0.81 FAAH (0.50) FAAHTRPV1TSHRTERTPTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 182 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024146993-A1 HYDROSILYLATION PROCESS CATALYSED BY A MANGANESE COMPLEX ELKEM SILICONES FRANCE SAS (FR) 2024-07-11 WO disclosed
EP-4395931-A1 HYDROSILYLATION METHOD CATALYSED BY AN IRON COMPLEX Elkem Silicones France SAS (FR) 2024-07-10 EP disclosed
EP-4396266-A1 HYDROSILYLATION PROCESS CATALYSED BY A COBALT COMPLEX Elkem Silicones France SAS (FR) 2024-07-10 EP disclosed
WO-2024141095-A1 METHOD FOR MANUFACTURING 3D PRINTED ARTICLE USING A PHOTOCURABLE SILICONE COMPOSITION ELKEM SILICONES SHANGHAI CO., LTD. (CN) 2024-07-04 WO disclosed
CN-118284465-A Hydrosilylation process catalyzed by iron complexes 埃肯有机硅法国简易股份公司 2024-07-02 CN disclosed
CN-118265742-A Hydrosilylation process catalyzed by cobalt complexes 埃肯有机硅法国简易股份公司 2024-06-28 CN disclosed
CN-115335233-B Method for additive manufacturing of silicone elastomer articles 埃肯有机硅法国简易股份公司 2024-05-28 CN disclosed
EP-3635034-B1 METHOD FOR MANUFACTURING A SILICONE ELASTOMER ARTICLE USING A 3D PRINTER ELKEM SILICONES FRANCE S A S (FR) 2024-05-22 EP disclosed
US-20240109256-A1 A METHOD OF ADDITIVE MANUFACTURE OF A THREE-DIMENSIONAL ARTICLE MADE OF A CURED MATERIAL AND A GEL LIKE SUPPORT FOR USE IN ADDITIVE MANUFACTURING ELKEM SILICONES FRANCE SAS (FR) 2024-04-04 US disclosed
WO-2024068044-A1 POST-TREATMENT OF A 3D-PRINTED ELASTOMER SILICONE ARTICLE. ELKEM SILICONES FRANCE SAS (FR) 2024-04-04 WO disclosed
WO-2012017138-A1 NOVEL HYDROSILYLATION CATALYSTS BLUESTAR SILICONES FRANCE (FR) 2012-02-09 WO disclosed
EP-1278809-B1 SILICONE/ADHESIVE COMPLEX WHEREOF THE INTERFACE HAS A RELEASE FORCE CAPABLE OF BEING MODULATED BY ELECTRON BEAM IRRADIATION RHODIA CHIMIE SA (FR) 2005-11-09 EP disclosed
US-20050038277-A1 Use of a catalyst system based on a platinum group metal and a heterocyclic organic compound for hydrosilylation of unsaturated reagents RHODIA CHIMIE (FR) 2005-02-17 US disclosed
US-6824848-B2 FOR USE IN ADHESIVE PROTECTIVE PAPERS, LABELS, DECORATIVE PAPERS AND ADHESIVE TAPES RHODIA CHIMIE (FR) 2004-11-30 US disclosed
EP-1440112-A1 USE OF A CATALYTIC SYSTEM BASED ON PLATINUM GROUP METAL AND A HETEROCYCLIC ORGANIC COMPOUND FOR HYDROSILYLATION OF UNSATURATED REAGENTS RHODIA CHIMIE (FR) 2004-07-28 EP disclosed
US-20030186013-A1 Silicone/adhesive complex whereof the interface has a release force capable of being modulated by electron beam irradiation RHODIA CHIMIE (FR) 2003-10-02 US disclosed
WO-2003037962-A1 USE OF A CATALYTIC SYSTEM BASED ON PLATINUM GROUP METAL AND A HETEROCYCLIC ORGANIC COMPOUND FOR HYDROSILYLATION OF UNSATURATED REAGENTS RHODIA CHIMIE (FR) 2003-05-08 WO disclosed
EP-1278809-A1 SILICONE/ADHESIVE COMPLEX WHEREOF THE INTERFACE HAS A RELEASE FORCE CAPABLE OF BEING MODULATED BY ELECTRON BEAM IRRADIATION RHODIA CHIMIE (FR) 2003-01-29 EP disclosed
WO-2001085864-A1 SILICONE/ADHESIVE COMPLEX WHEREOF THE INTERFACE HAS A RELEASE FORCE CAPABLE OF BEING MODULATED BY ELECTRON BEAM IRRADIATION RHODIA CHIMIE (FR) 2001-11-15 WO disclosed
US-5795947-A RELEASE PAPER COATINGS RHONE-POULENC CHIMIE (FR) 1998-08-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050038277-A1 Use of a catalyst system based on a platinum group metal and a heterocyclic organic compound for hydrosilylation of unsaturated reagents PPIH, OGDH, CTH FAAH 853/4885TRPV1 2772/4885TSHR 3703/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.